which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Development of vaccines for infectious diseases has come a long way with recent advancements in adjuvant developments and discovery of new antigens that are capable of eliciting strong immunological responses for sterile eradication of disease. Tuberculosis (TB) that kills nearly 2 million of the population every year is also one of the highlights of the recent developments.The availability or not of diagnostic methods for infection has implications for the control of the disease by the health systems but is not related to the immune surveillance, a phenomenon derived from the interaction between the bacteria and their...
Approximately 2 million people die of tuberculosis (TB) each year. The current vaccine, Bacille Calm...
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin ...
Clinical trials of vaccines against Mycobacterium tuberculosis are well under way and results are st...
PubMedID: 30474542Background: Mycobacterium tuberculosis (Mtb) is considered as one of the most effi...
Abstract: In this review we discuss recent progress in the development, testing, and clinical evalua...
One of the aims of the World Health Organisation (WHO) Millennium Development Goals (MDG) is to redu...
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that sits in t...
BACKGROUND: Mycobacterium tuberculosis (Mtb) is considered as one of the most efficacious human path...
BACKGROUND: Mycobacterium tuberculosis (Mtb) is considered as one of the most efficacious human path...
Tuberculosis (TB) is now among the top ten causes of mortality worldwide being resulted in 1.7 milli...
Background: one of the World Health Organization Millennium Development Goal is to reduce tuberculos...
In this review we discuss recent progress in the development, testing, and clinical evaluation of ne...
International audienceTuberculosis (TB) is now among the top ten causes of mortality worldwide being...
International audienceTuberculosis (TB) is now among the top ten causes of mortality worldwide being...
Abstract: Despite the efforts of the global medical and scientific community, tuberculosis remains t...
Approximately 2 million people die of tuberculosis (TB) each year. The current vaccine, Bacille Calm...
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin ...
Clinical trials of vaccines against Mycobacterium tuberculosis are well under way and results are st...
PubMedID: 30474542Background: Mycobacterium tuberculosis (Mtb) is considered as one of the most effi...
Abstract: In this review we discuss recent progress in the development, testing, and clinical evalua...
One of the aims of the World Health Organisation (WHO) Millennium Development Goals (MDG) is to redu...
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb) that sits in t...
BACKGROUND: Mycobacterium tuberculosis (Mtb) is considered as one of the most efficacious human path...
BACKGROUND: Mycobacterium tuberculosis (Mtb) is considered as one of the most efficacious human path...
Tuberculosis (TB) is now among the top ten causes of mortality worldwide being resulted in 1.7 milli...
Background: one of the World Health Organization Millennium Development Goal is to reduce tuberculos...
In this review we discuss recent progress in the development, testing, and clinical evaluation of ne...
International audienceTuberculosis (TB) is now among the top ten causes of mortality worldwide being...
International audienceTuberculosis (TB) is now among the top ten causes of mortality worldwide being...
Abstract: Despite the efforts of the global medical and scientific community, tuberculosis remains t...
Approximately 2 million people die of tuberculosis (TB) each year. The current vaccine, Bacille Calm...
Tuberculosis (TB) remains the deadliest infectious disease. The widely used bacille Calmette–Guérin ...
Clinical trials of vaccines against Mycobacterium tuberculosis are well under way and results are st...